Morgan Stanley
PHAR

Morgan Stanley’s Pharming Group PHAR Stock Holding History

Morgan Stanley’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$191K Buy
11,489
+3,789
+49% +$64.2K ﹤0.01% 5894
2025
Q4 		$136K Buy
7,700
+3,345
+77% +$52.6K ﹤0.01% 6076
2025
Q3 		$63.1K Buy
4,355
+1,455
+50% +$18.1K ﹤0.01% 6323
2025
Q2 		$31K Hold
2,900
– – ﹤0.01% 6509
2025
Q1 		$24.3K Buy
2,900
+300
+12% +$2.69K ﹤0.01% 6502
2024
Q4 		$26.2K Sell
2,600
-700
-21% -$5.96K ﹤0.01% 6493
2024
Q3 		$27.2K Buy
3,300
+500
+18% +$3.96K ﹤0.01% 6403
2024
Q2 		$23.4K Hold
2,800
– – ﹤0.01% 6408
2024
Q1 		$29.4K Sell
2,800
-2,800
-50% -$33.1K ﹤0.01% 6376
2023
Q4 		$64K Buy
5,600
+3,100
+124% +$35.5K ﹤0.01% 6307
2023
Q3 		$28.5K Hold
2,500
– – ﹤0.01% 6371
2023
Q2 		$29.1K Hold
2,500
– – ﹤0.01% 6426
2023
Q1 		$33.8K Sell
2,500
-4,149
-62% -$52.4K ﹤0.01% 6426
2022
Q4 		$73.3K Sell
6,649
-101
-1% -$1.12K ﹤0.01% 6117
2022
Q3 		$66K Buy
6,750
+4,250
+170% +$42.9K ﹤0.01% 6277
2022
Q2 		$22K Hold
2,500
– – ﹤0.01% 6938
2022
Q1 		$22K Hold
2,500
– – ﹤0.01% 7109
2021
Q4 		$22K Sell
2,500
-48
-2% -$425 ﹤0.01% 7186
2021
Q3 		$24K Hold
2,548
– – ﹤0.01% 7035
2021
Q2 		$29K Buy
2,548
+2,500
+5,208% +$31.1K ﹤0.01% 6875
2021
Q1 		$1K Buy
+48
New +$669 ﹤0.01% 7366

Other funds holding PHAR

SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SHIM
Stone House Investment Management Tunkhannock, Pennsylvania $558M AUM 14.72% 1-Year Est. Return

Morgan Stanley's PHAR Position: Q1 2026 in Review

Morgan Stanley increased its Pharming Group (PHAR) stake by 49% in Q1 2026, buying an estimated $64.2K and bringing the position to 11,489 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #5894.

Morgan Stanley first reported a position in PHAR in Q1 2021 and has held it in 21 quarters since. 12 funds tracked by Wall St. Rank hold PHAR as of Q1 2026.

  • Morgan Stanley held 11,489 shares of Pharming Group worth $191K as of Q1 2026.
  • Morgan Stanley bought 3,789 Pharming Group shares in Q1 2026, an estimated $64.2K.
  • Pharming Group made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5894 holding.
  • Morgan Stanley first reported a position in Pharming Group in Q1 2021 and has held it in 21 quarters since.
  • 12 funds tracked by Wall St. Rank held Pharming Group as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.